• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国医疗器械公司非结构化医疗数据的必要性、可获取性及获取成本

Necessity, accessibility and acquisition cost of unstructured medical data for South Korean medical device companies.

作者信息

Kim Myung-Gwan, Lee InHo, Han HyunWook, Yu HyeongWon

机构信息

Institute for Biomedical Informatics, School of Medicine, CHA University, Seongnam, Korea (the Republic of).

Department of Biomedical Informatics, CHA University, Soengnam, Korea (the Republic of).

出版信息

BMJ Health Care Inform. 2025 May 31;32(1):e101472. doi: 10.1136/bmjhci-2025-101472.

DOI:10.1136/bmjhci-2025-101472
PMID:40451262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12142156/
Abstract

OBJECTIVE

This research aimed to identify the needs and priorities concerning structured and unstructured medical data of medical device companies engaged in developing medical software or hardware.

METHOD

The study was conducted between 23 March and 26 March 2023 and involved a survey of 76 managers, each of whom represented a single Korean medical device company.

RESULT

Companies focused on novel medical devices and software expressed higher demand for unstructured data than for structured data. However, the accessibility of unstructured data was hampered by high acquisition costs, and both structured and unstructured data suffered from limited openness and high pricing, hindering the progress of digital healthcare technology. To promote the development of innovative medical devices and software with increased value, these challenges must be addressed promptly.

DISCUSSION

A crucial solution involves establishing a secure medical data trade platform that ensures the exchange of reliable and accurate medical information while adhering to legal regulations. By facilitating the circulation of high-quality medical data at appropriate prices through an invigorated medical data trade ecosystem, numerous medical device development companies with innovative ideas will have the opportunity to challenge the industry, consequently lowering the entry barriers to development.

CONCLUSION

This holds the potential to revolutionise the medical device industry by enabling safe, efficient and equitable access to medical data, fostering groundbreaking advancements in healthcare technology.

摘要

目的

本研究旨在确定从事医疗软件或硬件开发的医疗设备公司在结构化和非结构化医疗数据方面的需求和优先事项。

方法

该研究于2023年3月23日至26日进行,涉及对76位经理的调查,每位经理代表一家韩国医疗设备公司。

结果

专注于新型医疗设备和软件的公司对非结构化数据的需求高于结构化数据。然而,非结构化数据的获取成本高昂,阻碍了其可访问性,并且结构化和非结构化数据都存在开放性有限和定价高昂的问题,这阻碍了数字医疗技术的发展。为了促进具有更高价值的创新医疗设备和软件的开发,必须迅速解决这些挑战。

讨论

一个关键的解决方案是建立一个安全的医疗数据交易平台,确保在遵守法律法规的同时交换可靠和准确的医疗信息。通过活跃的医疗数据交易生态系统,以适当的价格促进高质量医疗数据的流通,众多有创新想法的医疗设备开发公司将有机会挑战该行业,从而降低开发的进入壁垒。

结论

这有可能通过实现安全、高效和公平地获取医疗数据,推动医疗技术的突破性进展,从而彻底改变医疗设备行业。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/eabae35286fa/bmjhci-32-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/2a4ee42dbcc7/bmjhci-32-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/7ec104e5942c/bmjhci-32-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/deb14008a6f9/bmjhci-32-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/eabae35286fa/bmjhci-32-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/2a4ee42dbcc7/bmjhci-32-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/7ec104e5942c/bmjhci-32-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/deb14008a6f9/bmjhci-32-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef8/12142156/eabae35286fa/bmjhci-32-1-g004.jpg

相似文献

1
Necessity, accessibility and acquisition cost of unstructured medical data for South Korean medical device companies.韩国医疗器械公司非结构化医疗数据的必要性、可获取性及获取成本
BMJ Health Care Inform. 2025 May 31;32(1):e101472. doi: 10.1136/bmjhci-2025-101472.
2
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
3
Short-Term Memory Impairment短期记忆障碍
4
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
5
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Hail Lifestyle Medicine consensus position statement as a medical specialty: Middle Eastern perspective.欢呼将生活方式医学作为一门医学专业的共识立场声明:中东视角。
Front Public Health. 2025 Jun 20;13:1455871. doi: 10.3389/fpubh.2025.1455871. eCollection 2025.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Benefits and challenges of Big Data in healthcare: an overview of the European initiatives.大数据在医疗保健中的益处和挑战:欧洲倡议概述。
Eur J Public Health. 2019 Oct 1;29(Supplement_3):23-27. doi: 10.1093/eurpub/ckz168.
2
Artificial Intelligence in Medical Practice: The Question to the Answer?人工智能在医疗实践中的应用:问题的答案?
Am J Med. 2018 Feb;131(2):129-133. doi: 10.1016/j.amjmed.2017.10.035. Epub 2017 Nov 7.
3
The real cost of sequencing: scaling computation to keep pace with data generation.测序的实际成本:扩展计算能力以跟上数据生成的步伐。
Genome Biol. 2016 Mar 23;17:53. doi: 10.1186/s13059-016-0917-0.
4
Next generation sequencing and bioinformatic bottlenecks: the current state of metagenomic data analysis.下一代测序和生物信息学瓶颈:宏基因组数据分析的现状。
Curr Opin Biotechnol. 2012 Feb;23(1):9-15. doi: 10.1016/j.copbio.2011.11.013. Epub 2011 Dec 9.